Inactivation of Human Cytochrome P450 Enzymes and Drug–Drug Interactions-Reference-Cited by-同舟云学术

Inactivation of Human Cytochrome P450 Enzymes and Drug–Drug Interactions

Published:2009-10-24 Issue: Volume: Page:473-495
ISSN:
Container-title:Enzyme- and Transporter-Based Drug-Drug Interactions
language:
Short-container-title:

Author:

Obach R. Scott,Fahmi Odette A.,Walsky Robert L.

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4419-0840-7_19.pdf

Reference64 articles.

1. Baer BR, Wienkers LC and Rock DA (2007) Time-dependent inactivation of P450 3A4 by raloxifene: identification of Cys239 as the site of apoprotein alkylation. Chem Res Toxicol 20:954–964.

2. Bertelsen KM, Venkatakrishnan K, Von Moltke LL, Obach RS and Greenblatt DJ (2003) Apparent mechanism-based inhibition of human CYP2D6 in vitro by paroxetine: comparison with fluoxetine and quinidine. Drug Metab Dispos 31:289–293.

3. Correia M and Ortiz de Montellano PR (2005) Inhibition of cytochrome P450 enzymes, in Cytochrome P450 Structure, Mechanism, and Biochemistry (Ortiz de Montellano PR ed) pp 247–322, Kluwer Academic/Plenum Publishers, New York.

4. Delaforge M, Jaouen M, and Mansuy D (1984) The cytochrome P-450 metabolite complex derived from troleandomycin: properties in vitro and stability in vivo. Chem-Biol Int. 51:371–376.

5. De Matteis F (1974) Covalent binding of sulfur to microsomes and loss of cytochrome P-450 during the oxidative desulfuration of several chemicals. Mol. Pharmacol. 10:849–854.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selectivity of Dietary Phenolics for Inhibition of Human Monoamine Oxidases A and B;BioMed Research International;2019-01-23

2. Statistical Methods for Analysis of Time-Dependent Inhibition of Cytochrome P450 Enzymes;Drug Metabolism and Disposition;2012-08-31

3. Mechanism of cytochrome P450-3A inhibition by ketoconazole;Journal of Pharmacy and Pharmacology;2011-01-14

4. Use of clearance concepts and modeling techniques in the prediction of metabolic drug–drug interactions;Trends in Pharmacological Sciences;2010-08